IP
International S.A. Pharmstandard
10% Owner

International S.A. Pharmstandard insider trades: Argos Therapeutics (ARGS) stock purchases

10% Owner, Argos Therapeutics Last trade Oct 7, 2016 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2014
2
Companies
last trade 2016

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where International reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Oct 7, 2016ARGS↑ Buy$150K
Oct 3, 2016ARGS↑ Buy$196K
Sep 29, 2016ARGS↑ Buy$199K
Sep 20, 2016ARGS↑ Buy$223K
Sep 16, 2016ARGS↑ Buy$251K
Sep 1, 2016ARGS↑ Buy$81K
Aug 24, 2016ARGS↑ Buy$252K
Aug 24, 2016ARGS↑ Buy$305K
Aug 22, 2016ARGS↑ Buy$320K
Oct 27, 2014PRTO↑ Buy$6.0M
Feb 12, 2014ARGS↑ Buy$10.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About International S.A. Pharmstandard's insider trades

International S.A. Pharmstandard is a 10% owner of Argos Therapeutics (ARGS). Since Feb 12, 2014, International has reported 11 open-market purchases worth $18.2M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (6 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARGS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.